NeuroOne Medical Technologies Corporation (NMTC)Healthcare | Medical Devices | Eden Prairie, United States | NasdaqCM
2.66 USD
-0.22
(-7.639%) ⇩
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 7:03 a.m. EDT
The company is trapped in a severe structural decline, having lost over 93% of its value over the last seven years. While recent headlines highlight a reverse stock split to regain compliance and a CEO buying shares, these actions cannot mask the reality of deteriorating fundamentals: the business is burning cash with negative operating margins and negative free cash flow. The price action confirms this distress, trading well below its 50-day and 200-day moving averages with no signs of a trend reversal. With no dividend to provide income and a balance sheet showing significant debt relative to equity, there is no margin of safety here. The recent insider purchase is likely a forced sale or a small stake in a sinking ship, insufficient to alter the bearish thesis. Investors should avoid this security until there is concrete evidence of a turnaround in profitability and revenue growth. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.208250 |
| MSTL | 0.232316 |
| AutoETS | 0.237817 |
| AutoTheta | 0.260155 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 50.03 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.138 |
| Excess Kurtosis | -1.35 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 3.852 |
| Revenue per Share | 1.527 |
| Market Cap | 23,149,932 |
| Forward P/E | -9.50 |
| Beta | 0.53 |
| Profit Margins | -52.23% |
| Website | https://nmtc1.com |
As of July 11, 2026, 7:03 a.m. EDT: Speculators are positioning defensively with heavy put volume relative to calls, particularly at the $5.00 strike where open interest is concentrated. Implied volatility is significantly elevated for near-term puts compared to calls, indicating a fear of downside gaps or continued weakness rather than a bullish breakout. The lack of significant call open interest above current prices suggests limited speculative capital betting on an immediate recovery.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.33793104 |
| Address1 | 7,599 Anagram Drive |
| All Time High | 180.0 |
| All Time Low | 2.37 |
| Ask | 3.47 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 71,800 |
| Average Daily Volume3 Month | 45,977 |
| Average Volume | 45,977 |
| Average Volume10Days | 71,800 |
| Beta | 0.529 |
| Bid | 2.97 |
| Bid Size | 4 |
| Book Value | 0.624 |
| City | Eden Prairie |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.66 |
| Current Ratio | 4.382 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 2.88 |
| Day Low | 2.66 |
| Debt To Equity | 3.852 |
| Display Name | NeuroOne Medical |
| Earnings Call Timestamp End | 1,778,589,000 |
| Earnings Call Timestamp Start | 1,778,589,000 |
| Earnings Timestamp | 1,778,589,000 |
| Earnings Timestamp End | 1,786,624,200 |
| Earnings Timestamp Start | 1,786,624,200 |
| Ebitda | -6,809,345 |
| Ebitda Margins | -0.53529 |
| Enterprise To Ebitda | -2.986 |
| Enterprise To Revenue | 1.598 |
| Enterprise Value | 20,331,832 |
| Eps Forward | -0.28 |
| Eps Trailing Twelve Months | -0.89 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.6901 |
| Fifty Day Average Change | -1.0300999 |
| Fifty Day Average Change Percent | -0.2791523 |
| Fifty Two Week Change Percent | -33.793102 |
| Fifty Two Week High | 6.96 |
| Fifty Two Week High Change | -4.3 |
| Fifty Two Week High Change Percent | -0.6178161 |
| Fifty Two Week Low | 2.565 |
| Fifty Two Week Low Change | 0.09500003 |
| Fifty Two Week Low Change Percent | 0.03703705 |
| Fifty Two Week Range | 2.565 - 6.96 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,521,120,600,000 |
| Float Shares | 7,853,224 |
| Forward Eps | -0.28 |
| Forward P E | -9.5 |
| Free Cashflow | -5,359,147 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 18 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.24681 |
| Gross Profits | 3,139,660 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.1512 |
| Held Percent Institutions | 0.22754999 |
| Implied Shares Outstanding | 8,702,982 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,021-05-26 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,759,190,400 |
| Last Split Date | 1,776,297,600 |
| Last Split Factor | 1:6 |
| Long Business Summary | NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota. |
| Long Name | NeuroOne Medical Technologies Corporation |
| Market | us_market |
| Market Cap | 23,149,932 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_412033082 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -6,643,648 |
| Next Fiscal Year End | 1,790,726,400 |
| Non Diluted Market Cap | 23,280,476 |
| Number Of Analyst Opinions | 3 |
| Open | 2.88 |
| Operating Cashflow | -7,433,723 |
| Operating Margins | -0.87858003 |
| Payout Ratio | 0.0 |
| Phone | 952 426 1383 |
| Previous Close | 2.88 |
| Price Hint | 4 |
| Price To Book | 4.2628207 |
| Price To Sales Trailing12 Months | 1.8198495 |
| Profit Margins | -0.52227 |
| Quick Ratio | 3.096 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.22 |
| Regular Market Change Percent | -7.63889 |
| Regular Market Day High | 2.88 |
| Regular Market Day Low | 2.66 |
| Regular Market Day Range | 2.66 - 2.88 |
| Regular Market Open | 2.88 |
| Regular Market Previous Close | 2.88 |
| Regular Market Price | 2.66 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 17,592 |
| Return On Assets | -0.71681 |
| Return On Equity | -2.0443602 |
| Revenue Growth | 0.725 |
| Revenue Per Share | 1.527 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 8,702,982 |
| Shares Percent Shares Out | 0.0033000002 |
| Shares Short | 28,845 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 33,927 |
| Short Name | NeuroOne Medical Technologies C |
| Short Percent Of Float | 0.0034 |
| Short Ratio | 0.93 |
| Source Interval | 15 |
| State | MN |
| Symbol | NMTC |
| Target High Price | 13.0 |
| Target Low Price | 8.0 |
| Target Mean Price | 9.93333 |
| Target Median Price | 8.8 |
| Total Cash | 2,804,011 |
| Total Cash Per Share | 0.325 |
| Total Debt | 206,973 |
| Total Revenue | 12,720,795 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.89 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.456995 |
| Two Hundred Day Average Change | -1.7969949 |
| Two Hundred Day Average Change Percent | -0.4031853 |
| Type Disp | Equity |
| Volume | 17,592 |
| Website | https://nmtc1.com |
| Zip | 55,344 |